Furthermore, all analogues were NMe-Gly11 substituted, showing higher resistance to peptidases, thus increasing the effective amount of the intact radioligand reaching the tumour sites (Abouzayed et al. 2023). This evidence concerns the gene LAP3 and neoplasm.